科研之友
微信
新浪微博
Facebook
分享链接
摘要
To evaluate the efficacy of a combined protocol of mifepristone and misoprostol in the management of early pregnancy failure (EPF) and the average time to expulsion of tissue and rate of side effects. %26lt;br%26gt;Retrospective chart review of all consecutive women treated with primary medical management for EPF at our institution from 2006 to 2012. %26lt;br%26gt;168 patients were included in the present study. The overall success rate, defined as the absence of the need for surgical intervention, was 61 % and did not differ by calendar year. There was no difference in success rate grouped by diagnosis [intrauterine embryonic/fetal demise (IUED/IUFD) vs. anembryonic gestation; p = 0.30] or gestational age (%26lt; 9 or a parts per thousand yen9 weeks; p = 0.48). The success rate varied significantly according to the required dose of misoprostol, a parts per thousand currency sign800 or %26gt; 800 mu g (68 vs. 50 %, p = 0.029). Of the possible predictive factors of success, only the dose of misoprostol required was a significant independent negative predictor. Mean and median time to tissue expulsion after the first dose of misoprostol were 8.4 and 5.5 h, respectively. The incidence of side effects was low with no blood transfusions required. %26lt;br%26gt;The success rate in this study is markedly below published data. This can possibly be attributed to retrospective study design, allowing for physician subjectivity and patients%26apos; wishes in the absence of strict study requirements. The protocol was well tolerated with a paucity of side effects. We make suggestions for enhancing success rates in the clinical setting by optimizing medication protocols, establishing precise treatment guidelines and training physicians in the accurate interpretation of treatment outcomes.
- 出版日期2014-6
